There was no correlation between the BDFN level and the UHDRS, disease stage, number of CAG repeats, and antidepressant treatment, and there were no significant differences in serum BDNF level of HD patients, both in the preclinical and symptomatic stages, compared to the control. This evidence concerns the gene BDNF and Huntington disease.